Global search

Find data and evidence

Type at least 2 characters. Use arrow keys to review and Enter to open.

Peer reviewedOpen accessLassaHemorrhagic FeverRift Valley feverEbolaMarburg virus diseaseCrimean-Congo hemorrhagic fever

Development of a non-infectious control for viral hemorrhagic fever PCR assays

PLOS Neglected Tropical Diseases·

Matthew A. Knox, Collette Bromhead, David TS Hayman

DOI
10.1371/journal.pntd.0011390
PMID
PMCID
OpenAlex
W4394995810
Study type
Journal article
Publisher
Public Library of Science (PLoS)
Article type
journal-article
Integrity
current

Why this research matters now

The paper addresses a practical need for safer positive controls in disease surveillance testing when authentic positive material is limited or poses handling risks. It is relevant to diagnostics and assay validation workflows.

01

Structured evidence summary

Research question

To create a non-infectious synthetic control that can support PCR assay development and validation for several viral hemorrhagic fever pathogens.

Study design

Laboratory assay-development and validation study using synthetic DNA oligonucleotides, in vitro transcription to RNA, dilution series testing, and RT-PCR/RT-qPCR evaluation.

Population and setting

No human or animal population is described. The work was conducted in laboratory settings for PCR-based detection assays for Crimean-Congo hemorrhagic fever, Ebola, Lassa, Marburg, and Rift Valley fever.

Main findings

The authors report that the synthetic control enabled successful recovery in RT-PCR and RT-qPCR and allowed limits of detection to be assessed across multiple laboratory settings. They also state that the approach is adaptable to diagnostic assays that need validation of nucleic acid extraction and/or amplification.

Public-health relevance

The paper addresses a practical need for safer positive controls in disease surveillance testing when authentic positive material is limited or poses handling risks. It is relevant to diagnostics and assay validation workflows.

Important limitations

No explicit study limitations are stated in the abstract. This summary is therefore limited to the supplied single-article abstract and metadata and should be checked against the full paper for decision-grade interpretation.

GIDS interpretation

This article is discoverable as a 2024 peer-reviewed diagnostics paper on assay validation for several viral hemorrhagic fevers. The topic links place it in a surveillance and laboratory-testing context, but this summary does not imply any live surveillance signal.

02

Related GIDS surveillance

Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.

03

Evidence relationships

This article has 12 auditable classifier relationships to diseases, places, topics, and study design.

about diseaseabout diseaseabout diseaseabout diseaseaddresses topicaddresses topicaddresses topicevaluates interventionhas pathogen typestudied population settingstudies pathogenuses study design